Answers are grounded in this paper and cite their sources.
Background: The application of topical medications to facilitate the healing process and prevent infection continues to be an essential component of treatment for all types of wounds. Methods: Silver nanoparticles loaded with sodium fusidate were produced through chemical reduction using trisodium citrate as the reducing agent. The silver nanoparticles were initially produced and then incorporated into a gel prepared using carbomer 940 and triethanolamine. The sodium fusidate-loaded silver nanoparticles were characterized by pH, polydispersity index (PDI), and globular diameter. Results: The novel formula exhibited a globular diameter of 668.2±0.2 nm, normal homogeneous dispersion (PDI, 0.567±0.002), and a pH of 6.2±0.05. Conclusions: To our knowledge, this is the first sodium fusidate-loaded silver nanoparticles nano-drug delivery system. Its preclinical and clinical applications seem promising.
No takes yet. Share an insight, caveat, or question.
Abdulkader et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: